Webasherman's syndrome, also known as intrauterine adhesions or synechiae, is a rare but clinically significant condition characterized by the formation of fibrous tissue within the.
Webherein, this review has summarized past therapeutic strategies, including postoperative adjuvant therapy, cell or therapeutic molecular delivery therapy methods.
Webasherman syndrome is a multifaceted condition describing the partial or complete removal of the uterine cavity and/or cervical canal.
It is a highly debatable topic because of its pronounced influence on both reproductive outcomes and gynaecologic.
Webintrauterine adhesions with symptoms like hypomenorrhea or infertility are known under the term asherman’s syndrome.
Although the syndrome has been widely.
Webloss of the basalis layer of the endometrium without formation of adhesive disease is referred to as “unstuck asherman’s” or endometrial sclerosis, and patients.
Webasherman syndrome is one of the endometrial factors that influence a woman’s reproductive capacity.
However, in our context, it needs to be well.
Webasherman syndrome is one of the endometrial factors that influence a woman’s reproductive capacity.
However, in our context, it needs to be well.
Webthe gold standard for diagnosis of asherman syndrome is hysteroscopy, which allows for direct visualization and concurrent procedural management.
Webintrauterine adhesions with symptoms like hypomenorrhea or infertility are known under the term asherman’s syndrome.
Although the syndrome has been widely.